The effect of air pollution on the changing pattern of glomerulopathy has not been studied. We estimated the profile of and temporal change in glomerular diseases in an 11-year renal biopsy series including 71,151 native biopsies at 938 hospitals spanning 282 cities in China from 2004 to 2014, and examined the association of long-term exposure to fine particulate matter of ,2.5 mm (PM 2.5 ) with glomerulopathy. After age and region standardization, we identified IgA nephropathy as the leading type of glomerulopathy, with a frequency of 28.1%, followed by membranous nephropathy (MN), with a frequency of 23.4%. Notably, the adjusted odds for MN increased 13% annually over the 11-year study period, whereas the proportions of other major glomerulopathies remained stable. During the study period, 3-year average PM 2.5 exposure varied among the 282 cities, ranging from 6 to 114 mg/m 3 (mean, 52.6 mg/m 3 ). Each 10 mg/m 3 increase in PM 2.5 concentration associated with 14% higher odds for MN (odds ratio, 1.14; 95% confidence interval, 1.10 to 1.18) in regions with PM 2.5 concentration .70 mg/m 3 . We also found that higher 3-year average air quality index was associated with increased risk of MN. In conclusion, in this large renal biopsy series, the frequency of MN increased over the study period, and long-term exposure to high levels of PM 2.5 was associated with an increased risk of MN.
primary glomerulopathy in some countries. 6, 13, 15 The temporal change in the pattern of primary glomerulopathy, especially within comparable ethnic groups in different countries, suggests the presence of unidentified environmental factors that have clinically significant effects on primary glomerular disease. However, no published studies have evaluated the effect of environmental factors on the changing pattern of glomerular diseases.
China comprises 20% of the world population. With rapid developments in its economy and urbanization, especially during the past decade, air pollution has become a public health problem in some cities. 16 Exposure to air pollution, especially particulate matter of ,2.5 mm (PM 2.5 ), has been associated with increased death and incidence of cardiovascular events. [17] [18] [19] Animal studies have shown that exposure to fine particulate promotes the production of autoantibodies and immune complexes and results in immune dysregulation 20, 21 which is implicated in the pathogenesis of some glomerulopathies. These findings led us to hypothesize that longterm exposure to air pollution may cause temporal changes in the profile of glomerulopathy in China. To date, the nationwide trend and composition of glomerulopathies has not been described, although several single-center biopsy series have reported the frequency of glomerular disease in China. 11, 22 In this study, we analyzed data from an 11-year renal biopsy series including 71,151 patients from 938 hospitals in 282 cities across China, encompassing all age groups and both tertiary and community hospitals, to evaluate the nationwide composition and secular pattern of glomerular diseases. We further examined the association between long-term exposure to PM 2.5 and specific types of glomerular diseases.
RESULTS

Study Participants
The study sample consisted of 71,151 independent cases with biopsy-proven glomerular diseases, from 938 hospitals across China (Supplemental Figure 1) . The demographic and clinical characteristics of the series are presented in Table 1 . The study population comprised mainly young to middle-aged adults (89%), with an average age of 37.3 years, split equally in gender but imbalanced in geographical presentation, hospital level, and year of biopsy. Over the study period, the numbers of biopsy patients and hospitals performing biopsy significantly increased. The percentage of patients aged .65 years increased from 3.3% in the period 2004 to 2006, to 6.0% in the period 2013 to 2014. Nephrotic syndrome (45.4%) and urinary abnormality (40.4%) were the most common indications for biopsy. The percentage of patients that received a biopsy due to nephrotic syndrome gradually increased, while those that were performed due to urinary abnormality decreased during the study period.
Composition and Secular Pattern of Glomerulopathy
Of the 70,626 patients with single glomerular disease, 77.5% had primary glomerulopathy. The disease spectrum varied with age (Table 2) . After age and region standardization, IgAN was the most common glomerulopathy during the study period, accounting for 36.3% of the primary glomerulopathies, followed by membranous nephropathy (MN; 30.2%). MN was the leading cause of nephrotic syndrome in adults aged .40 years, while minimal change disease (MCD) was the most common histologic diagnosis among those aged #39 years (Table 3) .
There was a remarkable rising trend in the frequency of MN over the period 2004 to 2014, while the frequencies of the other major glomerulopathies remained stable (Figure 1 ). The rising trend in MN was observed among all age groups and in all regions (Supplemental Figure 2) During the year of 2014, a total of 399 patients with biopsyproven MN without features of secondary disease had been tested for glomerular deposits of phospholipase A2 receptor, of which 332 (83%) were positive, validating the diagnosis of primary MN.
Air Pollution and Increased Frequency of MN
Frequency of MN varied greatly among geographical regions ( Figure 2A ). In our study, the frequency of MN was higher in the northern region, especially in Hebei province, the most polluted area in China ( Figure 2B ). This finding led us to hypothesize that air pollution might be associated with increased risk of MN. The 3-year average PM 2.5 derived from the aerosol optical depth (AOD) data 23 Higher levels of PM 2.5 exposure were associated with an increased risk of MN after adjusting for confounders including age, gender, geographic region, level of hospital for biopsy, pathologic laboratory, clinical syndrome, and year of biopsy ( Figure 2C) . The relationship appeared to be nonlinear: each increase of 10 mg/m 3 was associated with 14% higher odds for MN (OR, 1.14; 95% CI, 1.10 to 1.18) at PM 2.5 concentration above 70 mg/m 3 ; the curve was flat at PM 2.5 below 70 mg/m 3 (OR, 1.02; 95% CI, 0.99 to 1.04). The annual increase in odds for MN was greater in the cities with a higher PM 2.5 slope even after adjusting for geographic region (P=0.03) ( Figure 2D , Supplemental Figure 3 ). Assuming a causal relationship, 15.2% of MN in China could be attributable to PM 2.5 air pollution exposure.
As a validation to the exposure measurement, similar associations of MN with 3-year average air quality index 
DISCUSSION
To our knowledge, this is the first and the largest study of a nationwide biopsy series to examine the effect of air pollution on the changing pattern of glomerular diseases in China. Among 71,151 native renal biopsies encompassing all age groups from both tertiary and community hospitals across the country, we found a remarkable rise in the proportion of MN over a period of 11 years from 2004 to 2014. We also found that long-term (3-year average) exposure to high levels of PM 2.5 was associated with an increased risk of idiopathic MN, an autoimmune glomerulonephropathy involving the formation of circulating autoantibodies and immune complex deposits in the kidney. 24 In this study, we compared the frequencies of various glomerular diseases among age groups and clinical syndromes. IgAN was the most frequent glomerular disease with an ageand region-standardized frequency of 28.1% during the study period, accounting for 36.3% of all primary glomerulopathies. This is consistent with other studies from Asia, Australia, Europe, and some regions of the United States. [11] [12] [13] [14] Interestingly, MN emerged as the most frequent biopsy finding in patients aged .40 years. An age-and region-standardized frequency of MN was recorded in 23.4% of all biopsies, second in frequency to IgAN. A high frequency of MN has been reported in multiple studies of the elderly, especially those aged .65 years. 5, 10, 25 In our series, nephrotic syndrome was the indication for biopsy in 45.4% of the population. MN was the leading cause of nephrotic syndrome in adults aged .40 years, while MCD was the most common histologic diagnosis among those aged #39 years.
An important finding from this study is the remarkable rising trend in the frequency of MN over the past decade. From 2004 to 2014, the adjusted frequency of MN increased from 12.2% to 24.9% in this Chinese population. The risk for MN increased 13% annually in a regression analysis with adjustments for the confounders, including age and clinical characteristics. Projected from this trend, MN would soon pass IgAN to become the leading type of nephropathy in China. Although these results need to be interpreted in the context of an increasingly aggressive diagnostic approach to glomerular disease, this is unlikely to be the main cause for the increasing trend in MN frequency due to the following reasons. First, in our regression analysis of the trend, we adjusted for confounders including age, gender, region, clinical syndrome, pathologic laboratory, and hospital level for biopsy. Hence, the effects of aging and increased frequency in nephrotic syndrome in the biopsy population were already controlled. Second, the proportion of other major biopsy-proven glomerulopathies remained fairly stable during the study period, and the proportion of secondary MN, such as lupus nephritis and hepatitis B-associated nephritis, did not show a similar trend in the same population. Consistent with the previous reports, 26 most of the MN in our study were phospholipase A2 receptor-related, validating the diagnosis of primary MN. Third, there has been consistency in both the pathologic procedures and interpretations of biopsy specimens in the pathologic centers in charge of histologic diagnosis, and there were no substantial changes in the diagnosis of MN or differentiation of MN from other primary glomerular disease over the study period.
The large biopsy series with a wide coverage of 282 cities across China allowed us to examine the effect of exposure to air pollution on the risk of MN in the country. Table 1 ). In 2008, . 27 Most importantly, we found that long-term exposure to high levels of PM 2.5 was associated with an increased risk of MN after controlling for confounders including age, gender, region, year of biopsy, pathologic laboratory, level of hospital for biopsy, and clinical syndrome. Each increase of 10 mg/m 3 was associated with 14% higher odds for MN (OR, 1.14; 95% CI, 1.10 to 1.18) in regions with PM 2.5 concentrations above 70 mg/m 3 . Similar associations of MN with 3-year average AQI and PM 2.5 level measured by local monitors were also observed. The annual increase in odds for MN was greater in the cities with higher PM 2.5 slopes, even after adjusting for geographic region (P=0.03), though per capita disposable income, and educational and health care resources were comparable among these cities (Supplemental Table 2 ). Similarly, a previous study showed that neither education level nor household income significantly modified the relationship between air pollution and cardiovascular disease. 17 It is noteworthy that a rising trend in MN was also reported in India, 28 a country with a high level of environmental exposures. In comparison, MN was shown to be declining in other East Asian countries with low exposure levels, such as Japan 29 and Korea. 30 The mechanism(s) by which long-term exposure to fine particulate air pollution may increase the risk of MN remains to be elucidated. MN has been recognized as an autoimmune disease characterized by the formation of circulating autoantibodies and subepithelial immune complex deposits in the kidney. 24 Animal studies have shown that exposure to fine particulate promotes the production of autoantibodies and immunecomplexes. 20, 21 It has been hypothesized that cytokines generated in the airways in response to air pollution can spill over into the circulation, influencing autoimmune responses and distant events. 31 Supporting this notion, air pollution increases the circulating levels of inflammation mediators such as TNF-a, IL-6, and plasminogen activator inhibitor-1, 21, 32, 33 and genetic polymorphisms in these cytokines are associated with the development of MN. [34] [35] [36] [37] [38] It would also be interesting to test the existence of any interactions between PM 2.5 exposure and the genetic polymorphisms implicated in MN. 39 There were limitations in our study. First, our study was based on a renal biopsy series. Without registry data or sampling information for the biopsy specimens, we were not able to estimate the biopsy rate or incidence of glomerulopathy in the general population. However, under the setting of no temporal changes in the incidences of other glomerulopathies, an increased frequency of MN implies increased incidence of the disease. Second, information on patient residence was limited to the city level. As a result, we used citywide averages of PM 2.5 to approximate the individual exposures in the analysis, which may have led to an underestimation of the effect of PM 2.5 . The large number of cities included in our study and the great variation in PM 2.5 levels among these cities should have helped to alleviate this problem. Third, the PM 2.5 data we used in the analysis was not directly measured but derived from the satellite AOD. However, we found similar patterns of association between MN and the ground-based PM 2.5 levels as well as AQIs in our analysis (Figure 2, E and F) . A good agreement between AOD-derived and ground-based PM 2.5 levels has also been reported previously. 23 Finally, our study investigated the long-term (3-year) effect of PM 2.5 in a population with an unusually high level of exposure; the results may not be ascribed to a short-term effect or generalized to a lower level of exposure.
We confirmed a significant rising trend in the frequency of MN, which in our data was second only to IgAN as the leading type of glomerular disease in China. We provided evidence for the association between long-term exposure to PM 2.5 and risk for MN, especially at a high level of exposure. Our results call for further investigation on this topic using animal models and population-based prospective cohort studies.
CONCISE METHODS
Data Source
We collected data from six central pathologic laboratories on 75,163 renal biopsies from 938 hospitals spanning 282 cities across China, over an 11-year period from January 2004 to December 2014. The data, which was extracted from referral records and pathologic reports of renal biopsies, included: age, gender, city of residence, date and hospital performing the biopsy, clinical syndrome, laboratory measurements, and histologic diagnosis. In the current analysis, we excluded the patients without histologic diagnosis (374), those with repeated biopsies (714) and kidney graft (250), and those with missing demographic or clinical data (927). We further excluded the patients with isolated tubulointerstitial renal diseases (1747). The remaining 71,151 independent native biopsies with glomerular disease were subsequently analyzed. The Medical Ethics Committee of Nanfang Hospital, Southern Medical University approved the study protocol and waived patient consent.
Histologic Specimens and Diagnosis
All renal biopsies were processed and assessed at six central pathologic laboratories. Biopsy specimens were routinely analyzed by light microscopy and immunohistologic assays. In addition, 64% of the biopsy specimens in the series were also examined by electron microscopy. The histologic results were interpreted by six leading histopathologists. The histologic findings were classified according to the "Revised Protocol for the Histological Typing of Glomerulopathy" (WHO,1995) 40 and categorized into primary, secondary, mixed (patients with two concurrent glomerular diseases), and unclassified glomerular diseases. The primary glomerular diseases included IgAN, MN, MCD, FSGS, mesangial proliferative GN, membranoproliferative GN type 1, and others.
Data on Air Pollution Exposure
We obtained the 3-year average PM 2.5 grid data from 2004 to 2012, derived from satellite AOD at a resolution of 0.130.1 degrees (longitude by latitude), 23 from the Socioeconomic Data and Applications Center, National Aeronautics and Space Administration. In the current study, we estimated long-term exposure to PM 2.5 as the mean of the 3-year average PM 2.5 levels prior to the year of biopsy within an area of 131 degrees centered on the city of residence. In years 2013 and 2014, the PM 2.5 data were not available and were substituted by the PM 2.5 data for 2012. PM 2.5 data from local monitors in many cities were not publically available until late 2013. We were able to obtain monthly averages of locally measured PM 2.5 levels in 145 study cities during 2014, and used the yearly average in the analysis. The 3-year average AQIs of 162 cities in China from 2012 to 2014 were calculated from the daily AQIs reported by the Ministry of Environmental Protection of China (http://datacenter.mep.gov.cn). AQI uses whichever pollutant is the highest on the day, so it is not specific to a single pollutant. Nevertheless, PM 2.5 was the principal pollutant on two thirds of the days with AQI$100 during 2012 to 2014. The average AQIs of the cities without actual measurements were estimated by two-dimensional (longitude and latitude) smoothing of the AQI in nearby cities using the 'mgcv' R package. 41 
Statistical Analyses
We calculated the frequency of each glomerulopathy among all biopsy-proven glomerular diseases excluding mixed glomerular diseases. We used the age structure in the total biopsy population as the reference to calculate the age-adjusted frequency of each glomerulopathy in a region, and derived the overall standardized frequency as the average of all region-specific and age-adjusted frequencies weighted by the population sizes of the regions. We used a generalized additive logistic model to estimate the trend in frequency of each glomerulopathy (change in odds for the glomerulopathy and the corresponding proportion among patients with biopsy) during the study period with adjustments for age, gender, region, pathologic laboratory, hospital level, and clinical syndrome. We also used a generalized additive logistic model to estimate the effects of 3-year average PM 2.5 level on MN with adjustments for age, gender, region, pathologic laboratory, hospital level, year of biopsy, and clinical syndrome. We sought to confirm the association between air pollution and MN under the same statistical model, using the 3-year average AQI from 2012 to 2014 and the average PM 2.5 level measured by local monitors during 2014, respectively, as the pollution exposures, and limiting the biopsy series to 2012 to 2014. We estimated the population attributable fraction of PM 2.5 on MN empirically as the percentage of reduction in MN frequency under the generalized additive model if PM 2.5 exposure was reduced to 10 mg/m 3 . We calculated the rate of annual change in PM 2.5 (PM 2.5 slope) in an area as the slope of a simple linear regression of PM 2.5 with calendar year during the period 2004-2012. We divided 282 cities into "low", "medium", and "high" groups by PM 2.5 levels and PM 2.5 slopes, respectively, using the corresponding 25th and 75th percentiles as the cutoffs.
We compared the annual increases in odds for MN among different levels of PM 2.5 and PM 2.5 slope using the logistic regression model with adjustments for age, gender, region, pathologic laboratory, hospital level, and clinical syndrome. We used R version 3.2.0 for the statistical analyses, and, more specifically, the "mgcv" package version 1.8-6 for the generalized additive model. 41 
